Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem The Motley Fool 23:40 Fri, 07 Aug
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound The Motley Fool 20:36 Fri, 07 Aug
Will Strong Q2 Results and Higher 2026 Outlook Change Eli Lilly's (LLY) Narrative? Simply Wall St 08:42 Fri, 07 Aug
Eli Lilly, Novo Nordisk Antitrust Suit Tossed By Texas Judge Law360 20:19 Thu, 06 Aug Article paywall
Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology 11:19 Thu, 06 Aug
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs Barchart 21:00 Wed, 05 Aug
Eli Lilly raises annual revenue expectation as GLP-1 drugs fuel growth The Business Standard 20:04 Wed, 05 Aug
Market movers: Shopify, Uber, Eli Lilly, SolarEdge, CVS Health… Proactive Investors (Canada) 19:32 Wed, 05 Aug
Stock Market Midday, Aug. 5: Eli Lilly Pops and AMD Drops in Mixed Morning Markets The Motley Fool 17:56 Wed, 05 Aug
Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion Benzinga 17:11 Wed, 05 Aug Article paywall
Nasdaq Falls Over 100 Points; Eli Lilly Shares Gain On Upbeat Earnings Benzinga 17:01 Wed, 05 Aug Article paywall
CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal Benzinga 16:20 Wed, 05 Aug Article paywall
Eli Lilly Raises Sales Forecast As Weight Loss Drug Demand Soars. Its Stock is Climbing IBTimes (US) 16:08 Wed, 05 Aug
Le azioni di Eli Lilly salgono del 6% dopo utili Q2 sopra le stime grazie a Mounjaro e Zepbound Invezz 15:32 Wed, 05 Aug
Eli Lilly stock surges 6% after Q2 earnings beat driven by Mounjaro, Zepbound Invezz 15:30 Wed, 05 Aug
Eli Lilly lifts FY guidance as Mounjaro, Zepbound drive Q2 sales ShareCast 13:43 Wed, 05 Aug Article paywall
Eli Lilly lifts full-year forecast after revenue jumps 48% in second quarter Sweden Herald 12:37 Wed, 05 Aug
Eli Lilly (NYSE:LLY) Beats Expectations in Strong Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations Barchart 12:21 Wed, 05 Aug
Eli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer Simply Wall St 16:21 Tue, 04 Aug
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings Benzinga 13:12 Tue, 04 Aug Article paywall
Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients The Business of Fashion 12:50 Tue, 04 Aug
Eli Lilly Is Up 7% in 2026 and Has Major Catalysts on the Way. Is the Rally Just Getting Started? The Motley Fool 12:47 Tue, 04 Aug
Michigan Supreme Court Opens Door to Increased Mcpa Enforcement: Key Takeaways from Eli Lilly National Law Review 23:00 Mon, 03 Aug
STAT Plus: After Eli Lilly granted one man special access to obesity drug, doctors struggle to get answers STAT 18:30 Mon, 03 Aug
